comparemela.com

Latest Breaking News On - London stock exchange for the new ordinary - Page 27 : comparemela.com

ANGLE plc: Angle PLC Announces Exercise of options and total voting rights

ANGLE plc: Angle PLC Announces Exercise of options and total voting rights GUILDFORD, SURREY / ACCESSWIRE / May 19, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 216,000 new Ordinary shares of £0.10 each ( New Ordinary Shares ) in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ( Admission ) and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 24 May 2021. After Admission, the total number of Ordinary Shares in issue, and therefore the total number of voting rights, will be 215,867,845.

Investegate |Angle PLC Announcements | Angle PLC: Exercise of options and total voting rights

About ANGLE plc www.angleplc.com ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE s proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLE s cell separation technology is called the Parsortix ®   system, and it enables a liquid biopsy (a simple blood test) to be used to provide the cells of interest to the user in a format suitable for multiple types of downstream analyses. The system is based on a microfluidic device that captures cells based on a combination of their size and compressibility. The system is epitope independent and can capture all types of CTCs as well as CTC clusters in a viable form (alive). CTCs enable the complete picture of a cancer to be seen, as being an intact cell they allow DNA, RNA and protein a

ANGLE plc: Angle PLC Announces Exercise of Options and Total Voting Rights

ANGLE plc: Angle PLC Announces Exercise of Options and Total Voting Rights SURREY, UK / ACCESSWIRE / April 30, 2021 / ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 203,333 new Ordinary shares of £0.10 each ( New Ordinary Shares ) in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ( Admission ) and it is expected that Admission will become effective, and trading will commence at 8.00 a.m. on 7 May 2021. After Admission, the total number of Ordinary Shares in issue, and therefore the total number of voting rights, will be 215,651,845.

Investegate |FireAngel SafetyTech Announcements | FireAngel SafetyTech: Replacement

  The following amendment has been made to the Placings and Open Offer announcement released on 30 April 2021 at 7.00 a.m. under RNS No 1510X. The date underlined in the following sentence has been changed from June 2022 to 2024 within the body of the announcement: Thereafter, once production of the next generation smoke alarm has commenced, a royalty fee per product will be payable to the Company as the manufacturing partner, with a multi-million volume fee agreed for the initial thirty months, with a minimum royalty fee commitment of €3.0 million (estimated to exceed £1.0 million by 2024). All other details remain unchanged. The full amended text is shown below.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.